← all drugs
Fentanyl Citrate Injection
in shortage · Analgesia/Addiction · Snapshot: 2026-10-09
Day 5,395
of this shortage, counting from the FDA's first posting on 01/01/2012
- Manufacturers listed
- Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company
- Reported reason(s)
- Other; Demand increase for the drug
- Machine-readable
- JSON for this drug
Presentations (19)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28) | Hospira, Inc., a Pfizer Company | Limited Availability | 09/22/2026 |
| Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25) | Hospira, Inc., a Pfizer Company | Limited Availability | 09/22/2026 |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31) | Hospira, Inc., a Pfizer Company | Limited Availability | 09/22/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-09-26 — Fentanyl Citrate Injection: availability wording revised for 2 presentation(s)
- 2026-09-23 — Fentanyl Citrate Injection: availability wording revised for 1 presentation(s)
- 2026-09-17 — Fentanyl Citrate Injection: availability wording revised for 1 presentation(s)
- 2026-09-05 — Fentanyl Citrate Injection: availability wording revised for 1 presentation(s)
- 2026-09-03 — Fentanyl Citrate Injection: availability wording revised for 1 presentation(s)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.